GlassScriptPhysician profile
Carolyn Tran
NPI 1588330948
$7,053.19
in general payments reported to CMS, 2019-2025
31 companies · $1,530 in 2025
The $1,530 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $202 · 2022: $1,882 · 2023: $1,790 · 2024: $1,649 · 2025: $1,530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,969.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,968.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,511.46 | 2021-2025 | |
| Novo Nordisk INC | $1,354.22 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $781.12 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $680.48 | 2022-2025 | |
| Lilly USA, LLC | $643.36 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $427.70 | 2022-2025 | |
| Astellas Pharma US INC | $204.37 | 2022-2025 | Veozah |
| Amgen INC. | $166.12 | 2023-2025 | Repatha, Repatha, Otezla |
| Sanofi-Aventis U.S. LLC | $148.22 | 2022-2023 | |
| Exact Sciences Corporation | $123.75 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Organon LLC | $107.21 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.20 | 2021-2022 | |
| Glaxosmithkline, LLC. | $84.71 | 2025 | Shingrix, Arexvy, Bexsero |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $82.32 | 2023-2025 | Xifaxan |
| Seqirus USA INC | $72.36 | 2023-2025 | Flucelvax, Flucelvax Quadrivalent, Fluad Quadrivalent |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $70.63 | 2025 | Korlym |
| Merck Sharp & Dohme LLC | $69.34 | 2022-2025 | Verquvo, M-M-R II, Capvaxive |
| Daiichi Sankyo INC. | $60.58 | 2023-2024 | Injectafer |
| Cranial Technologies, INC | $60.10 | 2025 | Doc Band |
| Vanda Pharmaceuticals INC. | $58.87 | 2021-2022 | |
| Janssen Biotech, INC. | $28.28 | 2025 | Darzalex, Tecvayli |
| Sumitomo Pharma America, INC. | $27.95 | 2025 | Gemtesa |
| Hologic Sales and Service, LLC | $24.67 | 2022 | |
| Gilead Sciences, INC. | $24.44 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $23.96 | 2022 | |
| Amarin Pharma, INC. | $22.12 | 2022 | |
| Abbott Laboratories | $19.02 | 2025 | Freestyle Libre 3 |
| Ethicon US, LLC | $18.31 | 2024 | Linx Reflux Management System, Harmonic, Stratafix |
| Takeda Pharmaceuticals U.S.A., INC. | $18.00 | 2025 | Trintellix |
| Shield Therapeutics INC | $17.98 | 2022 | |
| Agios Pharmaceuticals, INC. | $14.34 | 2025 | Pyrukynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carolyn Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.